Financing round brings in $96M for Nectero | DOD contracts Cook Medical for implantable medical devices | Capitainer to boost US, EU sales efforts with new funds
Steris has announced the sale of its dental segment to Peak Rock Capital in a cash transaction of $787.5 million. The business includes Steris' infection control products and dental instruments.
Nectero Medical has secured $96 million during a completed Series D financing round. The company plans to use the proceeds to support a Phase 2/3 study and to pursue an FDA submission for its Nectero Endovascular Aneurysm Stabilization Treatment system.
The Department of Defense has given an ECAT contract to Cook Medical for implantable vascular medical devices, such as the Zilver PTX drug-eluting peripheral stent, Zenith aortic endografts and other vascular disease-related interventional devices. "With this contract, Cook implantable devices will be available to all US DOD hospitals in the US, Hawaii and Alaska and will expand to cover all overseas hospitals in the coming months," said Cook Medical VP of Supply Chain Ross Harvey.
Capitainer has raised additional funds of $2 million in a capital boost from Sciety and Sciety Venture Partners. The company, which develops self-sampling technology, intends to use the proceeds to support sales efforts in the US and Europe and boost production capacity.
A study found that the GeneSight Psychotropic test from Myriad Genetics was associated with a 29% decrease in hospitalizations and a 39% relative decrease in psychiatric-linked hospitalizations. The test is a genetic-based decision-support testing tool for gene analysis that aids clinicians in prescribing the proper medication.
A study in the European Heart Journal found that coronary computed tomography angiography combined with fractional flow reserve from CCTA may aid planning for coronary artery bypass grafting without the use of invasive coronary angiography data. "The key finding of this first-in-human study is the 99.1% feasibility, which is driven by the relatively good diagnostic concordance between CCTA and ICA," researchers said.
SpotSee has released its temperature indicator called TempMonitor. The single-use tool is for use by patients who take glucagon-like peptide-1 medications and insulin and provides visual indication when a medicine has been exposed to unacceptably elevated temperatures.
Roche has secured breakthrough device designation from the FDA for its Elecsys pTau217 plasma biomarker assay. The assay is used to determine the absence or presence of amyloid pathology, which is linked to Alzheimer's disease.
The Acolyte Image Guided Crossing and Re-Entry Catheter System from Simpson Intervention has gained breakthrough device designation from the FDA. The system aids in placing and positioning catheters and guidewires in the coronary vessels.
European regulators have given EU MDR certification to Getinge's Advanta V12 covered stent system to treat patients with aortoiliac occlusive disease. The system is used to treat patients with renal artery stenosis and/or aortoiliac occlusive disease.
Registration is open for AdvaMed's 101 Workshop: MedTech Coverage, Coding and Reimbursement! Our 101 program will discuss the "three-legged stool" of payment--coding, coverage, and reimbursement--as well as reviewing market access opportunities for novel technologies through both existing Medicare payment pathways and proposals to streamline Medicare policies in the future. Register for this virtual event to gain a comprehensive understanding of the basic principles of how medical technologies are covered and paid by insurers, the challenges medtech companies face and strategies they can use to achieve positive outcomes for coverage and appropriate reimbursement. Visit our website to view the Workshop agenda. Learn more.
Registration is open for the Payment Policy Forum happening in AdvaMed's Washington, D.C. office, May 21-22, 2024! This Forum is designed for experienced medtech professionals that have a deep understanding of the evolving landscape of payment policies. Join leaders from CMS, industry, and academia as they discuss payment for digital health technologies, private payer challenges, new CMS policies and more. This Forum will provide attendees with actionable strategies for achieving successful payment outcomes for their organization. Network with your fellow peers and get tips on how to navigate working with CMS during this two-day event. Visit our website to view the preliminary agenda. Learn more.
.png)
